1D
1.43%
0.53%
1W
-1.81%
-0.4%
1M
0.35%
-0.3%
YTD
119.74%
8.69%
1Y
126.16%
7.21%
3Y
171.54%
37.41%
5Y
263.04%
80.85%
10Y
26.71%
232.81%
- Stock Absolute Returns
- Absolute Returns
Total Returns (Price + Dividend) 
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
22.79%
0%
22.79%
6 Months
171.19%
0%
171.19%
1 Year
126.16%
0%
126.16%
2 Years
93.56%
0%
93.56%
3 Years
171.54%
0%
171.54%
4 Years
186.94%
0%
186.94%
5 Years
263.04%
0%
263.04%
Concord Drugs for the last several years.
What is a Quartile?
Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.
Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on
Return Quartiles - by Closest Peers 
Inconsistent Performance
Concord Drugs Ltd has not been a consistent performer in the YTD and longer periods
1
Quartile
QTD
25.38%
1
Quartile
Jun-Sep
61.27%
1
Quartile
Mar-Jun
33.2%
1
Quartile
YTD
123.67%
4
Quartile
2024
-36.37%
1
Quartile
2023
83.47%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry 
Inconsistent Performance
Concord Drugs Ltd has not been a consistent performer in the YTD and longer periods
1
Quartile
QTD
25.38%
1
Quartile
Jun-Sep
61.27%
1
Quartile
Mar-Jun
33.2%
1
Quartile
YTD
123.67%
4
Quartile
2024
-36.37%
1
Quartile
2023
83.47%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap 
Not enough Stock Price history for Quartile Analysis
Risk Adjusted Returns v/s 
Returns Beta
Beta has not been calculated since enough price history is not available






